IRIS
QUINTO, ILEANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.585
AS - Asia 2.225
EU - Europa 1.081
SA - Sud America 395
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 7.331
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.452
SG - Singapore 1.082
CN - Cina 537
IT - Italia 508
BR - Brasile 314
VN - Vietnam 214
IN - India 183
DE - Germania 147
SE - Svezia 136
GB - Regno Unito 108
CA - Canada 97
FI - Finlandia 55
KR - Corea 46
HK - Hong Kong 38
AR - Argentina 25
MX - Messico 25
BD - Bangladesh 23
FR - Francia 22
NL - Olanda 18
EC - Ecuador 17
JP - Giappone 17
ZA - Sudafrica 17
ID - Indonesia 16
UA - Ucraina 15
ES - Italia 10
RU - Federazione Russa 10
PE - Perù 9
IQ - Iraq 8
PL - Polonia 8
VE - Venezuela 8
CL - Cile 7
CZ - Repubblica Ceca 7
IL - Israele 7
CO - Colombia 6
RO - Romania 6
SA - Arabia Saudita 6
PK - Pakistan 5
PY - Paraguay 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
GR - Grecia 4
IR - Iran 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
CH - Svizzera 3
DZ - Algeria 3
EU - Europa 3
IE - Irlanda 3
JM - Giamaica 3
TH - Thailandia 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
BB - Barbados 2
EE - Estonia 2
KG - Kirghizistan 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
SY - Repubblica araba siriana 2
BH - Bahrain 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
JO - Giordania 1
KW - Kuwait 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
TT - Trinidad e Tobago 1
Totale 7.331
Salva come PNG Salva come JPEG
Città #
San Jose 559
Dallas 420
Chandler 393
Singapore 377
Ashburn 284
Santa Clara 167
Bengaluru 140
Hefei 140
Milan 138
Lawrence 134
Princeton 134
Munich 114
Beijing 88
Catanzaro 80
Ho Chi Minh City 80
Wilmington 76
London 69
Ottawa 67
Turku 49
Chicago 47
Des Moines 45
Hanoi 43
Boardman 39
Seattle 39
Hong Kong 37
Los Angeles 30
São Paulo 26
Shanghai 23
Naples 21
Napoli 20
Guangzhou 18
New York 17
Brooklyn 16
Taranto 15
Montreal 14
San Francisco 14
Augusta 13
Gwangjin-gu 13
Redmond 13
Rome 13
The Dalles 13
Columbus 12
Shenzhen 11
Haiphong 10
Johannesburg 10
Seoul 10
Boston 9
Marano 9
Norwalk 9
Rio de Janeiro 9
Tokyo 9
Paris 8
Stockholm 8
Warsaw 8
Amsterdam 7
Da Nang 7
Foggia 7
Olomouc 7
Pune 7
Thái Bình 7
Xi'an 7
Council Bluffs 6
Gangbuk-gu 6
Hanover 6
Helsinki 6
Mexico City 6
Mumbai 6
Orem 6
Redwood City 6
Atlanta 5
Buffalo 5
Guayaquil 5
Hadfield 5
Jiaxing 5
Manchester 5
Phoenix 5
Buenos Aires 4
Campinas 4
Cleveland 4
Denver 4
Dongyang 4
Edmonton 4
Fortaleza 4
Guarulhos 4
Latina 4
Lima 4
Padova 4
Quito 4
Reggio Calabria 4
Ribeirão Preto 4
Salvador 4
Timisoara 4
Toronto 4
Turin 4
Wuhan 4
Ann Arbor 3
Arco 3
Bangkok 3
Bari 3
Biên Hòa 3
Totale 4.383
Salva come PNG Salva come JPEG
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 148
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 102
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. 97
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 95
Comparative toxicity of diphenyl, diphenyl ether and some of their hydroxyderivatives 93
A novel phage display based platform for exosome diversity characterization 92
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 88
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 86
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 84
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtk-gamma 83
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 82
B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy 81
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 81
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 80
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43 79
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 77
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 76
Crucial role for IBtk in the survival and maintenance of mature B cells 75
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder 75
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 74
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 73
Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65 73
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 73
Cancer-associated CD43 glycoforms as target of immunotherapy 73
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 71
IkappaB-alpha Represses the Transcriptional Activity of the HIV-1 Tat Transactivator by Promoting Its Nuclear Export 71
Cancer-associated CD43 glycoforms as target of immunotherapy 70
Computational analysis and in vivo validation of a microRNA encoded by the IBTK gene, a regulator of B-lymphocytes differentiation and survival 69
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 69
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 68
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 68
Inhibition of HIV-1 replication in primary human monocytes by the IkappaB-alfaS32/36A repressor of NF-kappaB 68
The aftermath of the Merck's HIV vaccine trial 67
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 67
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 67
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 67
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 65
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 61
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 60
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 60
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 59
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 59
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 59
A comparative study on the toxicity and mutagenicity of biphenyl (BP) and diphenyl ether (DPE) in sea urchin, S. typhimurium and S. cerevisiae. 58
A NF-kB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kB-activating stimuli 58
Molecular characterization of tumor-derived exosomes as tool for minimal residual disease monitoring 58
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 58
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 58
Autocrine growth function of interleukin-1 and interleukin-6 molecules on human transformed B cells 57
Phage Display: An Overview in Context to Drug Discovery 57
High attenuation and immunogenicity of a simian immunodeficiency virus expressing a proteolysis-resistant inhibitor of NF-kappa B 57
Spontaneous and mutagen-mediated amplification of a neo gene integrated at different genomic sites in Rat 2 fibroblasts 56
I tests di mutagenesi nella valutazione della tossicologia dei farmaci. 56
Crucial role for IBtkgamma in the survival and maintenance of matureB cells 56
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 56
DNA damaging agents increase the stability of interleukin-1alfa, interleukin-1beta and interleukin-6 transcripts and the production of the relative proteins 56
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 56
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 55
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 55
Partial purification and MALDI-TOF MS analysis of UN1, a tumor antigen membrane glycoprotein 55
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 54
Mutagenicity of twelve imidazole derivatives with trichomonacide activity 54
High efficiency of site-directed mutagenesis mediated by a single PCR product 54
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 54
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 54
Carcinogenic potency in rodents versus genotoxic potency in E. coli: a correlation analysis for bifunctional alkylating agents 53
Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors 53
Phage Display: An Overview in Context to Drug Discovery 52
Exosome-associated miRNAs profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 52
Effect of DNOC, Ferbam and Imidan exposure on mouse sperm morphology 51
Aspetti generali di tossicologia genetica 51
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 51
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 51
Epstein-Barr Virus Nuclear Antigen 2 transactivates the Long Terminal Repeat of Human Immunodeficiency Virus Type 1 50
Insights into Thymus Development and Viral Thymic Infections 50
Expression of an exogenous interleukin-6 gene in human EBV-B cells confers growth advantage and in vivo tumorigenicity 49
Regulation of the HIV Promoter/Enhancer 49
Structural and functional insights into IκB-α/HIV-1 Tat interaction. 47
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 47
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 47
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 47
Ultraviolet Mutagenesis 47
Screening of 24 pesticides by Salmonella/microsome assay: mutagenicity of benazolin, metoxuron and paraoxon. 46
Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle 46
Metodo di attenuazione stabile di retrovirus HIV-1 e SIV per acquisizione di funzione: sviluppo di un virus vaccino attenuato per l'AIDS 46
Genotoxicity and teratogenicity of diphenyl and diphenyl ether: a study of sea urchins, yeast, and Salmonella typhimurium 46
Frameshift mutagenicity of furocoumarins in the dark 46
Multimodal Imaging for a Theranostic Approach in a Murine Model of B-cell Lymphoma with Engineered Nanoparticles 46
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 46
Impaired generation of bone marrow B-lymphocytes in mice deficient in C/EBP beta 45
Further validation of the E. coli multitest: in vitro and in vivo metabolic activation of procarcinogens 45
Sperm abnormalities in mice exposed to diesel particulate 43
Perspectives for a Protective HIV-1 Vaccine in "HIV-1: Molecular Biology and Pathogenesis" 43
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 42
Mutagenic epoxide impurities discovered in two beta-adrenergic blocking agents 42
Polypeptide capable of inhibiting HIV-1 transcription and replication and uses thereof 42
Peptide-guided targeting of GPR55 for anti-cancer therapy. 42
Frameshift mutagenesis in the dark of furocoumarins proposed for photochemotherapy 41
Quantitative correlation between carcinogenic potencies and mutagenic, recombinogenic and SOS inducer potencies measured in an E. coli test system 41
MUTAGENS ENHANCE THE HIV-1, INTERLEUKIN-1 (IL-1), AND INTERLEUKIN-6 (IL-6) EXPRESSION THROUGH TRANSCRIPTIONAL OR POSTTRANSCRIPTIONAL MECHANISMS 41
Totale 6.153
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.908
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202161 0 0 0 0 0 0 0 0 0 48 1 12
2021/2022464 9 9 7 111 27 10 21 130 29 50 58 3
2022/20231.175 270 35 62 67 126 95 7 114 227 68 80 24
2023/2024477 98 60 60 25 28 116 3 15 6 7 19 40
2024/20251.693 242 96 93 56 136 186 26 46 245 93 185 289
2025/20263.261 197 381 566 490 332 159 400 206 366 164 0 0
Totale 7.453